Roheeth K. Pavana

Discovery of <i>N</i>-(2,6-Dimethylphenyl)-Substituted Semicarbazones as Anticonvulsants: Hybrid Pharmacophore-Based Design

Perumal Yogeeswari, Dharmarajan Sriram, R. Thirumurugan et al. · Journal of Medicinal Chemistry · 2005 · 135 citations

Molecular Pharmacology, Medicinal Chemistry, Hybrid Pharmacophore-based Design +13

Discovery of New Antitubercular Oxazolyl Thiosemicarbazones

Dharmarajan Sriram, Perumal Yogeeswari, Rathinasababathy Thirumurugan et al. · Journal of Medicinal Chemistry · 2006 · 103 citations

Thiosemicarbazone 6Q, Medicinal Chemistry, Pulmonary Tuberculosis +15

Discovery of Antitubulin Agents with Antiangiogenic Activity as Single Entities with Multitarget Chemotherapy Potential

Aleem Gangjee, Roheeth K. Pavana, Michael A. Ihnat et al. · ACS Medicinal Chemistry Letters · 2014 · 43 citations · Full text

Pharmacotherapy, Tumor Biology, Single Entities +19

Implementation of the CYP Index for the Design of Selective Tryptophan-2,3-dioxygenase Inhibitors

Brendan T. Parr, Richard Pastor, Benjamin D. Sellers et al. · ACS Medicinal Chemistry Letters · 2020 · 27 citations · Full text

Discovery and preclinical evaluation of 7-benzyl-N-(substituted)-pyrrolo[3,2-d]pyrimidin-4-amines as single agents with microtubule targeting effects along with triple-acting angiokinase inhibition as antitumor agents

Roheeth K. Pavana, Shruti Choudhary, Anja Bastian et al. · Bioorganic & Medicinal Chemistry · 2016 · 17 citations · Full text

Medicinal Chemistry, Preclinical Evaluation, Antitumor Agents +9